This specialized case study explores Kymanox’s approach to development and implementing a Continued Process Verification (CPV) program for bioconjugate drug substance manufacturing at a Contract Manufacturing Organization (CMO). Our team of SMEs collaborated closely with stakeholders to implement measurable improvements across process monitoring, risk reduction, and operation readiness for commercial manufacturing.
CHALLENGE
SOLUTION
RESULTS
- Develop and implement a CPV program for a bioconjugate drug substance manufacturing process at a contract manufacturer.
- Provide strong project leadership and technical oversight to ensure compliance and operational readiness.
- Delivered comprehensive technical project management and oversight.
- Analyzed the Client’s existing process control strategy and summarized historical batch data to strengthen process understanding for commercial manufacture.
- Used process knowledge to determine crucial parameters for inclusion in the CPV program and applied statistical tools for effective data monitoring.
- Developed detailed procedures for data collection, CPV review meetings, communication with the CMO, data analysis, and annual reporting.
- Implemented a robust, phase-appropriate CPV protocol tailored for commercial manufacturing needs.
- Successfully established a CPV program for the Client, complete with a comprehensive system for ongoing program management.
- Achieved timely protocol deployment, reducing operational risks and ensuring program robustness prior to commercial batches.
- Delivered high Client satisfaction that led to expanded requests for Kymanox’s technical services support across other projects.